Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer

Clinical trial NCT01999673 · COMPLETED

Trial details

NCT number: NCT01999673
Sponsor: Peregrine Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small-Cell Lung Cancer Stage IIIB Non-Small-Cell Lung Cancer Stage IV Non-Small-Cell Lung Cancer Metastatic Carcinoma, Non-Small-Cell Lung Non-Small Cell Lung Cancer Non-Small-Cell Lung Carcinoma Nonsmall Cell Lung Cancer

Start date: 2013-12-01
Primary completion: 2017-03-01
Enrollment: 582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.